INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.880
+0.050 (2.73%)
At close: Dec 22, 2025, 4:00 PM EST
1.870
-0.010 (-0.53%)
After-hours: Dec 22, 2025, 6:18 PM EST
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $49.98 million as of December 22, 2025. Its market cap has decreased by -53.71% in one year.
Market Cap
49.98M
Enterprise Value
23.33M
1-Year Change
-53.71%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $49.98M, a decrease of -35.78%. That is a compound annual growth rate of -6.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 49.98M | -51.73% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | 231.57M | 270.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |